Somers Deirdre's Form 4 filing
Enfusion, Inc. (ENFN) · filed Jan 12, 2024
- Accession no.
- 0001104659-24-003781
- Filed
- Jan 12, 2024
- Trade date
- Jan 10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $15.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Somers DeirdreCIK 0001956425 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | Class A Common Stock | SSaleDisposed | −1,770 | $8.65F2 | −$15,310.5 | 34,471 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.59 to $8.77. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.